Recent

% | $
Quotes you view appear here for quick access.

Pacific Biosciences of California, Inc. Message Board

  • paulieme60 paulieme60 Nov 13, 2013 5:54 PM Flag

    November 12th, 2013- PacBio Posts Slides from User Group Meeting

    Lance Hepler, Center for AIDS Research, UC San Diego

    Hepler used the PacBio RS to study intra-host diversity in HIV-1. He compared PacBio’s performance to that of 454®, the platform he and his team previously used. Hepler noted that in general, there was strong agreement between the platforms; where results differed, he said that PacBio data had significantly better reproducibility and accuracy.
    John Huddleston, University of Washington

    Huddleston is looking at challenging regions in the human genome, noting
    that assembly accuracy needs to be quite high to resolve breakpoints and
    reconstruct duplication architectures. His team is working with BACs to
    validate the use of the PacBio platform as a faster, more cost-effective
    alternative to Sanger. In one study, his team found that PacBio results
    had 99.994% identity with Sanger results and showed uniform coverage
    across the clone.
    Lisbeth Guethlein, Stanford University School of Medicine

    Guethlein looked at highly repetitive and variable regions of the
    orangutan genome. Guethlein reported that “PacBio managed to accomplish
    in a week what I have been working on for a couple years,” (with
    Sanger) and the results were concordant.
    (LOT More,go to IHUB for link)

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • More from User Group Meeting
      Alex Copeland, DOE – Joint Genome Institute

      Copeland offered an overview of the institute’s microbial and fungal reference assembly pipeline, describing their experience with a 10x increase in read length and total throughput in three years on the PacBio platform. He shared that the team has shifted to a PacBio-only pipeline, and that they are finishing genomes on the platform for less than $2,000.

 
PACB
7.030.00(-0.07%)Jul 1 4:00 PMEDT